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The role of some growth factors and cytokines in the 
pathogenesis of systemic sclerosis (SSe) has been 
suggested. In particular, the contribution of trans-
forming growth factor f3 in the progression of skin 
sclerosis is suspected. Connective tissue growth fac-
tor (CTGF) was originally identified in human umbil-
ical vein endothelial cells, and a recent study has 
revealed that human skin fibroblasts produce CTGF 
after stimulation with transforming growth factor {3. 
In the present study, the distribution of CTGF gene 
expression in tissue sections from patients with SSe 
was investigated by digoxigenin-labeled itt situ hy-
bridization. Strong CTGF mRNA signals were ob-
served in the fibroblasts in sclerotic lesions, espe-
s 
ystcmic sclerosis (SSe) is a connective tissue disease 
characterized by excessive fibrosis in the skin and many 
internal organs. Although the pathogenesis of SSe is 
poorly understood, it has been suggested that growth 
factors and cytokines released fi·om inflammatory cells in 
the o rgan involved play an important ro le in the initiation of 
connective ti ssue fibrosis. Among these, tran sforming growth 
factor (3 (TGP-(3) has recently ga ined atte ntio n as an important 
factor in the pathogenesis o f SSe [1 ]. TGF-(3 is secreted from 
macrophages and lymphocytes [2 ,3] and increases the production of 
coll age n and fibronectin by fibroblasts in rdtro [4,5]. TGF-(3 is also 
known to have indirect mitogenic activity o n fibroblasts, and this 
mitogeni c activity appears to be de penden t on the autocrine 
production of platelet-derived growth factor (PDGF)-related pep-
tides [ 6- 8). ln clinical investigations, several laboratories have 
reported the occurrence of elevated expressio n of TGF-(3 in skin 
biopsies from patien ts with SSe by immuno histoche mica l staining 
or ;, sil11 hybridization [9-14 ]. In o th er sclerotic s.kin disorders 
including mo rph ea, eosinophilic fasciitis, and keloids, expressio n of 
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cially in the deep dermis, of the skin specimens from 
patients with SSe, whereas there was no expression in 
the skin from normal controls. The number of fibro-
blasts with positive hybridization signals was more 
abundant in the dermis from the sclerotic stage than 
in that from the inflammatory stage. Our findings 
indicate a correlation between CTGF gene expression 
and skin sclerosis and support the hypothesis that 
transfortning growth factor-{3 plays an important role 
in the pathogenesis of SSe, because transforming 
growth factor f3 is the only inducer for CTGF identi-
fied to date. Key words: TGF-f3/fiiJYoblasts/fibrosisli11 sit11 
ltybridiz atioll. J Invest Dermatol 105:280-284, 1995 
TGF-{3 has also been demonstrated [14-1 6]. Thus, TGF-(3 is 
suspected to play an important rol e in the pathogenesis of fibrosis. 
Connective tissue growth factor (CTGF) is a cysteine-rich 
peptide originally identifi ed from human umbilical endothelial cells 
(HUVE) that exhibit PDGF-like chemotactic and mitogenic activ-
ities fo r m esenchym al ceUs and appears to be antigenically related to 
PDGF, although it has little peptide sequence homology to either 
the PDGF A orB chain peptides [17] . Our recent study showed that 
human foreskin fibroblasts produce high levels of CTGF mRNA 
and pro te in after activation with TGF-(3 but not other growth 
factors including PDGF, epide rm al g rowth factor, or basic fibro-
blast growth factor [1 8]. In the wound-chamber model, coordinate 
TGF-{3 expression followed by CTGF in regenerating tissue has 
been observed , suggesting a cascade p1·ocess for control of tissue 
regeneration and repair [1 8]. Thus, CTGF is a candidate autocrine 
stim ulator released in response to TGF-(3 in skin fibrobla sts and 
appears to part icipate in the process of ski11 fi brosis. However, the 
contribution of CTGF to the disease process of sclerotic skin 
disorders has not been investiga ted previously. 
To determine the relationship between CTGF and the disease 
process of SSe, we inves tigated the expression ofCTGF mRNA in 
biopsy specimens from SSe by i11 sit11 hybridization. Marked CTGF 
gene expression was observed in the fibroblasts located in the 
sclerotic lesio n from patients with SSe, but not in sections from 
patients with SSe that showed no histologic sclerosis or from 
normal contro ls. Our findings indicated a signifi cant correlation 
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between CTGF gene expression and skin sclerosis, providing 
further evidence that TGF{3 is an important factor in the pathogen-
esis of fibrosis, as this factor is the onJy inducer of CTGF gene 
expression identified to date. 
MATERIALS AND METHODS 
Cell Culture Skin fib roblasts derived from normal control subjects were 
grown from explants of biopsies. Cell s were cultured in Dulbccco's 
modified Eagle's medium supplemented with 1 O'X, fetal bovine serum. 
In c ubation was maintained in T25 fla sks at 37°C in 95% air and 5% C02 . 
The cells were the n explanted into multiweiJ chamber slides . After reaching 
confluency, cell s were treated with 10 ng/ml ofTGF-{31 (R & D Systems, 
Inc., Minneapolis, MN) for 4 h, rinsed with phosphate-buffered sa line (PBS) 
fixed with 4% paraformaldehyde in PBS , air-dried , and subjected to i11 siw 
hybridization. Cells were used for experiments at the second or third 
passage. 
Patients Besides fi ve nonnal skin contro ls, biopsies ·were taken fron1 15 
patients with SSe (14 wome n , mean age 45, range 14-61 ) , one patient with 
nll.xed connective tissue disease, and on e with prin1ary Raynaud's disease . 
All patients had Raynaud' s phenomenon as an initial sign of the di sease . SSe 
patients fulfilled the preliminao·y criteria for SSe proposed by the American 
Rheumatism Association (ARA) [19). According to the classifi ca tion of 
LeRoy et nl [20) , 11 patients had diffuse cutaneous SSe and four patients had 
lim:ited cutaneous SSe . All biopsy specimens were obtaiued from the dorsum 
o f the forearm . All samples were fixed in neutral buffered formalin , 
e mbedded in paraffin, and prepared for hemato>:y lin-eosin examination . On 
hematoxylin-eosin examination, 12 of 15 patients with SSe d emonstrated 
histologic sclerosis in the dermis. Of these patients, three patients (three 
diffUse cutaneous SSe, mean age 42 , range 30-49; mean disease duration 
4 years, range 1-10 years) showed clinica l and histologic signs of the 
inflammatory stage of SSe, with a marked perivascular and periappendagea l 
Jytnphocytic iufiltration in the d ermis. Nine patients (two limi ted cutaneous 
> SSe, seven dilfuse c utaneous SSe, mean age 43, range 14-60; mean disease 
duration 4 years; range 4 months to 16 years) represented the sclero ti c stage 
of SSe. T he dermal co llagen bundles were packed and thickened , and the 
denno-epidermal junctions were flattened . Dermal sclerosis extended into 
the subjacent adipose tissue. Three patients (two limi ted cutaneous SSe. one 
di.ffi.ose cu taneous SSe, mean age 57, range 53-61; mean di sease duration 12 
years, range 8 -18 years) showed no hi stologic sclerosis, representing the 
atrophic stage . T he mixed connective tissue disease and primary R.aynaud' s 
' disease biopsies showed a low level of perivascular lymphoid ce ll infil tration 
but no derma l sclerosis. 
In Situ Hyln·idizatio rt Fonnalin-fixed, paraffin-embedded skin tissues 
were inves tigated using a sli ght modifi catio n of the nonradioactive i11 situ 
hybridization technique with digoxi.gen.in-labeled !t.N A probes . Briefly, 
paraffin-embedded sections w e re cut at a thickness of 4 p.m. mounted on 
silane-coated slides. deparaffini zed , and treated with 0.2 M H C l for 15 min 
fo llowed by 1.5 mg/ ml proteinase K digestion for 15 min at 37°C . T he 
sections w ere post-fixed with 4% paraformaldehydc in PBS for 5 min and 
, treated with PBS containing 2 mg/ ml g lycine twice for 15 min each time. 
After rinsing with PBS , the samples were soaked in two times standard 
saline citrate buffer (SSC) with 50% formamide and subjected to hybridiza-
tion. 
A 2100-bp fragment from CTGF eDNA was subcloned into the EcoR.l 
site ofBluescript pbagemid [17) and used for making probes. The DNA was 
linearized using the restriction enzymes Xba ! (to prepaTe antisense strand) 
or Xhol (to prepare sense strand). The probes were labeled with digoxigc-
nin-11-UTP using a DIG RNA-labeling kit (Boehringer Mannhcim Bio-
chemica , Gernlall)')-
The labeled RNA probe (final 1 p.g/ml) in a mixture containing 50% 
fo rrnamide, 10% dextran sulfnte, 1 X Denhardt's solu tion, 100 p.g/ ml 
tRN A. 5 X SSC, 0.25% sodium dodecylsulf.,te, l mM eth ylenediaminc-
tetraacetic acid and 50 mM NaH 2P0.1 was placed o n the slides and covered 
wid~ a coverslip . Hybridization was performed in a humidified chamber for 
18 hat 45 °C, after which the specimens w ere washed in 2 X SSC with 50% 
fo rrnamide at 50°C. Unhybridized probes were digested in 2.5 p.g/ ml 
RNasc A, 500 mM NaCl, ·t mM e thylcnediaminotctraacetic acid . and 10 
mM Tris HCI, pH 8. 0, for 15 min at 37°C. The slides were then wnshed for 
15 mi.u in 2 X SSC and in 0.2 X SSC nvice at 50°C. After posthybridization 
washing, digoxi.geu.in-l:obeled probes w ere visuali zed ns described in the 
DIG nucleic ncid d etectio n kit pro tocol (Boehringe r Mannhe im Bio-
chemica). T he sections were poststained with nuclcnr f., st red aud mounted. 
RESULTS 
Detection of CTGF mRNA in TGF-/3-Treated Cultured 
F ibroblasts We tried to d etermine whether the iu si/ 11 hybrid-
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A 
Figure 1. Iu situ hybridization of cultured huntan forearm skin 
fibroblasts from a normal control subject probed with CTGF 
antisense probe. A: nontreated. B: treated with 10 ng/ml ofTGF- {3 for 4 
h. Cultured fibroblasts were grown until confluency and trea ted with 
TGF-{3 as described. The cell s were fixed with 4% para fo rmalde hyd e in PBS 
and digoxigenin-labeled nonradioactive i11 si111 hybridization with CTGF 
antisense strand probe was performed as described in the text. 
ization method employed was effective. CuJtured human skin 
fibrobla sts are known to produce CTGF mRNA b y Northe m blot 
analysis after stimulation with TGF-{3 [18] . When confluent .fibro-
blasts fi-mn normal controls were h ybridized with antisense probe, 
only a trace level of staining was observed in non treated fibrobl asts 
(Fig lA), whereas a strong signal was seen in TGF-{3-trea te d 
fibroblasts (Fig lB) . Tl:tis r e sult indicates that this nonradioac tive in 
situ hybridization method effectively detec ts CTGF m.IlNA. 
No CTGF mRNA Expression in Normal Skin Fibroblasts 
Next, we investigate d CTGF gene express ion using biopsy speci-
m e ns. As shown in Fig 2 , no CTGF mRNA was e xpre ssed in 
d e rmal fibroblasts in aJJ fiv e normal controls. The e ndothelial cells 
of the blood vessels w e re a lso n egative. A slight nonsp ecific 
backgrow1d staining w as observed in the epidermal k e ratinocytes 
with both sense and antisense probes . 
CTGF mRNA Expression in the Fibroblasts in the Sclerotic 
Lesions ofSSc Specintens Whe n tissues fro m patie nts with SSe 
w e re examined b y i11 sit11 hybridization w ith the antisense strand 
CTGF probe, d e rmal fibroblasts were positive in aJI 12 cases that 
showed histologic sclerosis. Figure 3A is the hematox y lin-eosin 
stained section from the sclerotic stage of SSe, showing the 
·A 
Figure 2. No CTGF mRNA expression in the normal skin. A: 
antisense strand probe . B: sense strand probe. Digo >.; genin-labeled i11 si111 
hybridi zation of normal skin contro ls with CTG F gene probes w as pre-
formed as described in the text. Bnr, 100 p.m. 
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Figure 3. CTGF mRNA expression in the fibroblasts from patients with SSe in the sclerotic stage. The ti ssue from patients with SSe in the 
scle roti c stage was h ybridized w ith CT GF antisense strand pro be (B, C, D) and sen se strand probe (E). A , sam e lesion as B. is th e hematoxy lin-eosin stain ed 
section . C and E arc high magnifi cation of the lower dermis. A rniii'S in D po int to vascular e ndothelial ce ll s nega tive for CTGF mRNA. Bnrs: B , 2 50 f..lm ; 
C and E, 1 00 p.,m ; D. 25 p.,m. 
apparent sclerotic changes of collagen bundles in the whol e de rmis. 
As shown in Fig 3B, th e fibrobla sts disp laying CTGF mRNA 
scattered throughout the dermis. Figure 3 C demonstrates that 
CTGF mR.NA-positive fibrob lasts w e re more prominent in the 
lower dermis. Figure 3D shows the hi gh magnifica tion of fibro-
blasts expressing CTGF mRNA, whereas dennal vascu lar endothe-
lial cell s were negative for CTGF mRNA. To confirm the speci-
fi city of the hybridization , in si t11 hybridizatio n with CTGF sense 
strand probe was performed and no positive signal s were obtained 
(Fig 3E) . 
Fibroblasts with Positive Signals Are More Abundant in the 
Tissue from the Sclerotic Stage than That frott.l the Inflam-
matory Stage T issue from patients with SSe in the inflammatory 
stage also conta·in ed the fibroblasts positive for CTGF mRNA in 
the dermis , altho ugh the number of positive cell s was less th an that 
in the scl erotic stage. We o bserved no preferential distribution of 
CTGF mR.NA-positive fibrobbsts in the perivascular region s o r 
infl ammatory les ions in any of the samples examined (Fig 4). 
No CTGF mRNA Expression in the Tissue from the Atro-
phic Stage of SSe Figure 5A shows the hematoxylin-eosin 
stained sectio n of the biopsy speci men in the atrophic stage of SSe 
that has no histologic scle rosis. As shown in Fig 5B, CTGF mR.NA 
expressio n was not observed in that les ion. Also, the skin from the 
patients w ith M CTD and primary Raynaud 's disease showed no 
expression of CTGF mRNA (data not shown) . T hese findings 
sugges t that derma l sclerosis and CTGF ge ne expression arc 
significa ntl y correla ted. 
DISCUSSION 
R ecent studies have revealed the involvement of TGF-!3 in the 
progression of SSe [9-14]. We became inte rested in the CTGF 
gene expression in SSe skin tissues because CTGF production is 
Figure 4. CTGF mR.NA expression in the tissue section from 
patients with SSe in the inflammatory stage. The section was hybrid· 
ized with C TGF antisense strand probe. Arrows indicate the periappcndagcal 
lymphocytic infiltnttion. Note that the number o f fibrob lasts with positive 
signal s is less than that in Fig 3C. Bnr, 100 p.,m . 
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Figure 5. No CTGF mRNA expression in the fibroblasts from 
patients with SSe in the atrophic stage . A: hematoxylin-eosin stained 
section shows the loose arrangement of collagen bundles. B: the adjacent 
section was hybridized wi th CTGF antisense strand probe. Bnr, 100 J.Lll1 . 
u pregulated in cultured human skin fibrobla sts after stimul ation 
with TGF-/3 [1 8). CTGF is a secreted protein originally identifi ed 
from human umbilical endo th elial cells that exhibits PDGF-like 
activ ity [17]. It has ho mology to the 11-src-i.nduced CEF-1 0 peptide 
id e ntifi ed in chicken embryo fibrobla sts [21). cyr6"/ transcript 
clon ed fro m mouse BALB/ c 3T 3 fibrobla sts after se rum indu ction 
[22), and the se rum-induced.fisp1 2 [23 ] o r TGF-/3-induced /3IC M 2 
transcript iden tif ted in 3T3 cells [2 4]. CTGF is also related to the 
noll gene product that is overexpressed in nephroblastomas indu ced 
by m yelo blastosis-associated virus [25], ye t the biologic ro les o f 
th ese CTGF-related gene products arc poorl y understood . 
Our presen t findin gs clearly demonstrated C T GF mRNA ex-
pression iJJ skin fibro bl as ts located in the scle rotic les io ns fi·om 
pa tie nts with SSe, whereas th ere was no CTGF gene expressio n in 
sec tions tha t sh o w ed no histolog ic scl erosis. These res ults indicate 
the existence o f a significa nt correlatio n be tween skin fib rosis and 
CTGF gene expression, supporting the hypothesis that TGF-/3 pla ys 
an impo rtant ro le in the pathogenesis of SSe because CTGF is 
induced by T G F-/3 . 
C TGF mRNA-positive fibro blas ts w ere scatte red in sclerotic 
lesions and w ere pre fere nt ial.ly accumul ated in the deep dermis. 
Also, CTGF gen e expressio n was more pro minen t in the dermi s of 
patients in the fibroti c stage than ti·om th ose in the inflammatory 
stage. C onsidering these o bservations with the previ o us report of 
increased collagen synthesis observed mainly in fibro bl as ts grown 
from the deep de rmis of patients wi th SSe 126] , the level o f CTGF 
m.R.NA expression seems to correlate with the activity o f fibro-
blasts. 
It is unexpected, howe ver, that CTG F transcrip ts were present in 
cases of SSe with long duration even greater th an 10 years. This 
o b servation m ay indicate that the activity o f fibrobla sts in the 
sclerotic lesio n o f SSe persists in the long term, although T GF-/3 
seem s to ac t in the ve ry earlies t stage of the disease [9 ,1 0, 14]. W e 
sp eculate tha t unknown fa ctor(s) i11 ·11 i 11o may functio n to m aintain 
th e CTGF gene expression. A ltern atively, as the he terogeneity o f 
dermal fibro blasts has been suggested [27) , certain clones may 
achieve pe rmanent or pe rsistent alterati o n in biosynthe tic activ ity 
and elude normal TGF-/3 regulation. When dermal fibrobl as ts fro m 
pati.ents with SSe w ere cultured i11 11irro , w e recentl y found that the 
ex pression of C TGF in SSe fibroblas ts was greater th an that in 
n orma] fi bro blasts in the presence of TGF-/3 both in immunoblo t-
ting and re verse- transcriptase-polym erase chain reaction analys is , 
indicating the in creased response of SSe fibroblasts to T GF-/3 [28] . 
It is cl ea r that SSe fibroblasts express the CTGF gene differently 
from norm al fibroblasts, ye t further inves tigatio n is needed to 
clarify the m echanism of expressi on . 
D ermal blood vessel endothe lial cells did no t reveal CTGF 
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mKNA iJl tissue sectio ns, altho ugh CTGF is produ ced by c ul tured 
hum an umbili cal endo th eli al ce ll s. It rem ain s unclear whether this 
discrepan cy is due to the d iJfercnt ce ll types o r to the diffe re nces 
between i11 l' itro and i11 l! il'o co nditio ns. CTGF gene ex pression i.n 
inflammato t·y o r tum01·al diseases of blood vessels is now under 
inves tigation in o ur labo ratocy. 
T he regulation of CTGF gene and pro a l co llage n ge ne expres-
sio n appears to be simi lar , because both genes arc stim ulated by 
TG F-/3 and expressed in SSe skin t issues . Y et it re m ains unknown 
w he ther the expressio n of th ese tw o genes is synchroni zed in 
respo nse to o th e r sti mttli . TGI0-/3 is kn own to activate the p ro a 1 
coll agen gene via the nuclear facto r 1 site in irs p ro moter regio n 
[29] . H owever, th e existence o f TGF-/3-respo nsive elem ents in the 
promote r regio n o f the CTGF gene rem ains uncl ear. In addi t io n , it 
wil.l be of in teres t to in ves tigate the interaction between co llagen 
and CTGF in their expressio n . 
CTGF is a novel m embe r of the P DGF-re lated growth fa ctor 
famil y that is selectively induced by TGF- /3 in human skin fi bro-
bla sts and is suspected to pl ay an impo rtan t rol e dut·ing woun d 
hea ling and / or tissue regen eration . W e dem onstrated elevated 
C T GF gene expressio n in tbe skiJ1 fi·o m patie n ts with SSe, suggest-
ing a pathogenic contribu tio n to fibrotic conn ective d iso rders in 
which CTGF m ay act as an autocrine fa cto r in fi b roblas ts afte r 
stimulatio n w ith TGF- /3 . CTGF ge ne expressio n in othe r sclero tic 
skin disorders such as kelo id and scar tissues is now under exaJlli-
natio n , becau se th e bio logic role of CTGF is not yet fully under-
stood. 
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